Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.
The prophylactic effect of antibody to endotoxin core glycolipid was studied in surgical patients at high risk of gram-negative infection. At randomisation (on admission to intensive care unit), every 5 days thereafter, and at onset of septic shock, patients received plasma taken from donors before (control) or after immunisation with Escherichia coli J5, a mutant with only core determinants in its endotoxin. Gram-negative shock occurred in 15 of 136 controls and 6 of 126 J5 antibody recipients and related deaths in 9 of 136 and 2 of 126, respectively. J5 antibody was most effective in abdominal surgery patients, in whom shock occurred in 13 of 83 controls and 2 of 71 antibody recipients. Although antibody prophylaxis did not lower the infection rate, it prevented the serious consequences of gram-negative infections and thus improved the overall prognosis.
Baumgartner
J D
JD
Glauser
M P
MP
McCutchan
J A
JA
Ziegler
E J
EJ
van Melle
G
G
Klauber
M R
MR
Vogt
M
M
Muehlen
E
E
Luethy
R
R
Chiolero
R
R
D001424:Bacterial Infections / Q000453:epidemiology; D001428:Bacterial Vaccines; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004731:Endotoxins / Q000276:immunology*; D022361:Escherichia coli Vaccines; D005260:Female; D006017:Glycolipids / Q000276:immunology*; D006090:Gram-Negative Bacteria / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology; D011183:Postoperative Complications / Q000517:prevention & control; D011897:Random Allocation; D012772:Shock, Septic / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*
D001428:Bacterial Vaccines; D004731:Endotoxins; D022361:Escherichia coli Vaccines; D006017:Glycolipids; C042058:core endotoxin